The Safety of High Dose Labetalol in the Pregnant Population

Hypertension in pregnancy is one of the leading causes of maternal mortality and rapid treatment is critical. Treatment of emergent hypertensive crises in pregnancy is limited to only three medications, one of which is labetalol. Current literature recommends a daily maximum intravenous labetalol dose of 300 mg per day. However, this maximum dose has not been studied in pregnancy where higher doses may be required.

CardsJC: Chronic Hypertension and Pregnancy - CHAP Trial - Cardionerds Twitter Journal Club

Hypertension in Pregnancy: Current Perspective

Drug Treatment of Hypertension in Pregnancy

The Safety of High Dose Labetalol in the Pregnant Population

Relias Media

A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA), Trials

Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

PDF) Safety and efficacy of methyldopa and labetalol in controlling blood pressure in hypertensive disorders of pregnancy

These highlights do not include all the information needed to use LABETALOL HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for LABETALOL HYDROCHLORIDE. LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE injection , for

relatively safe antihypertensive drugs in pregnancy

Drugs in Gestational Hypertension – The Early Career Voice

Treatment for Mild Chronic Hypertension during Pregnancy

PDF) Drug Treatment of Hypertension in Pregnancy